Group One Trading
SGMO

Group One Trading’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Group One Trading’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$84K Sell
340,305
-159,874
-32% -$63.6K ﹤0.01% 4880
2025
Q4 		$210K Sell
500,179
-1,825
-0.4% -$967 ﹤0.01% 4323
2025
Q3 		$338K Buy
502,004
+269,834
+116% +$145K ﹤0.01% 4108
2025
Q2 		$126K Sell
232,170
-57,615
-20% -$34.2K ﹤0.01% 4767
2025
Q1 		$190K Buy
289,785
+86,904
+43% +$92K ﹤0.01% 4063
2024
Q4 		$207K Sell
202,881
-179,881
-47% -$329K ﹤0.01% 3916
2024
Q3 		$332K Buy
382,762
+114,326
+43% +$83.8K ﹤0.01% 3173
2024
Q2 		$96.2K Buy
268,436
+187,294
+231% +$101K ﹤0.01% 3995
2024
Q1 		$54.4K Sell
81,142
-210,326
-72% -$153K ﹤0.01% 4651
2023
Q4 		$158K Sell
291,468
-16,765
-5% -$7.73K ﹤0.01% 4068
2023
Q3 		$185K Buy
308,233
+190,465
+162% +$204K ﹤0.01% 3873
2023
Q2 		$153K Sell
117,768
-35,177
-23% -$48.1K ﹤0.01% 4208
2023
Q1 		$269K Sell
152,945
-19,204
-11% -$54.8K ﹤0.01% 3394
2022
Q4 		$541K Sell
172,149
-106,338
-38% -$413K ﹤0.01% 2974
2022
Q3 		$1.36M Buy
278,487
+27,338
+11% +$140K ﹤0.01% 2253
2022
Q2 		$1.04M Buy
251,149
+26,634
+12% +$115K ﹤0.01% 2719
2022
Q1 		$1.3M Sell
224,515
-15,643
-7% -$93K ﹤0.01% 2821
2021
Q4 		$1.8M Sell
240,158
-6,387
-3% -$55.5K ﹤0.01% 2719
2021
Q3 		$2.22M Buy
246,545
+76,504
+45% +$756K ﹤0.01% 2543
2021
Q2 		$2.04M Sell
170,041
-99,321
-37% -$1.12M ﹤0.01% 2627
2021
Q1 		$3.38M Sell
269,362
-9,282
-3% -$125K 0.01% 1911
2020
Q4 		$4.35M Buy
278,644
+163,875
+143% +$1.92M 0.01% 1391
2020
Q3 		$1.08M Sell
114,769
-34,795
-23% -$376K ﹤0.01% 2116
2020
Q2 		$1.34M Buy
149,564
+3,295
+2% +$30.6K 0.01% 1779
2020
Q1 		$932K Buy
146,269
+19,800
+16% +$147K 0.01% 1579
2019
Q4 		$1.06M Buy
126,469
+38,930
+44% +$358K 0.01% 1825
2019
Q3 		$792K Buy
87,539
+26,154
+43% +$293K 0.01% 1944
2019
Q2 		$661K Buy
61,385
+53,518
+680% +$569K 0.01% 1890
2019
Q1 		$75K Buy
+7,867
New +$80.3K ﹤0.01% 3352
2018
Q4 		– Sell
-156,777
Closed -$1.95M – 5356
2018
Q3 		$2.66M Buy
156,777
+69,272
+79% +$1.05M 0.02% 954
2018
Q2 		$1.24M Buy
87,505
+2,502
+3% +$41.6K 0.01% 1502
2018
Q1 		$1.61M Sell
85,003
-156,726
-65% -$3.35M 0.02% 1155
2017
Q4 		$3.96M Buy
241,729
+22,572
+10% +$336K 0.03% 771
2017
Q3 		$3.29M Sell
219,157
-16,801
-7% -$186K 0.03% 743
2017
Q2 		$2.08M Buy
235,958
+120,143
+104% +$771K 0.02% 933
2017
Q1 		$602K Sell
115,815
-72,765
-39% -$292K 0.01% 1719
2016
Q4 		$575K Buy
188,580
+47,493
+34% +$173K 0.01% 1672
2016
Q3 		$653K Sell
141,087
-3,848
-3% -$19.6K 0.01% 1611
2016
Q2 		$839K Buy
144,935
+4,562
+3% +$29.1K 0.01% 1370
2016
Q1 		$849K Buy
140,373
+112,003
+395% +$673K 0.01% 1297
2015
Q4 		$259K Sell
28,370
-38,995
-58% -$300K ﹤0.01% 2301
2015
Q3 		$380K Buy
67,365
+6,838
+11% +$56.4K 0.01% 2001
2015
Q2 		$671K Sell
60,527
-37,944
-39% -$489K 0.01% 1538
2015
Q1 		$1.54M Sell
98,471
-56,658
-37% -$877K 0.02% 784
2014
Q4 		$2.36M Sell
155,129
-19,660
-11% -$239K 0.04% 559
2014
Q3 		$1.89M Buy
174,789
+46,177
+36% +$603K 0.03% 722
2014
Q2 		$1.96M Buy
128,612
+77,434
+151% +$1.11M 0.03% 709
2014
Q1 		$925K Buy
51,178
+43,116
+535% +$831K 0.02% 1154
2013
Q4 		$112K Buy
+8,062
New +$92.8K ﹤0.01% 2933
2013
Q3 		– Sell
-25,341
Closed -$252K – 5533
2013
Q2 		$198K Buy
+25,341
New +$221K ﹤0.01% 2181

Other funds holding SGMO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Group One Trading's SGMO Position: Q1 2026 in Review

Group One Trading reduced its SANGAMO THERAPEUTICS INC (SGMO) stake by 32% in Q1 2026, selling an estimated $63.6K and leaving 340,305 shares worth $84K. The position accounts for ﹤0.01% of the portfolio, ranked #4880.

Group One Trading first reported a position in SGMO in Q2 2013 and has held it in 50 quarters since. The position peaked at $4.35M in Q4 2020. 112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.

  • Group One Trading held 340,305 shares of SANGAMO THERAPEUTICS INC worth $84K as of Q1 2026.
  • Group One Trading sold 159,874 SANGAMO THERAPEUTICS INC shares in Q1 2026, an estimated $63.6K.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #4880 holding.
  • Group One Trading first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and has held it in 50 quarters since.
  • Group One Trading's SANGAMO THERAPEUTICS INC position peaked at $4.35M in Q4 2020.
  • 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.